SCHEMBL8510685

SCHEMBL8510685

COC(=O)c1cc(OC(C)=O)c2cc(OC)ccc2c1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.51
MAPK8 P45983 1/20 0.47
RXFP1 Q9HBX9 1/20 0.43
BACE1 P56817 3/20 0.43
GABRA1 P14867 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
NR4A2 P43354 1/20 0.42
KDM4E B2RXH2 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9899615 0.93 PLA2G2A (0.49) PLA2G2AMAPK8RXFP1BACE1GABRA1
SCHEMBL6383895 0.93 BACE1 (0.51) PLA2G2ABACE1GABRA1GABRG2GABRB3
SCHEMBL17733151 0.89 ALDH1A1 (0.49) KDM4ECYP1A2CYP2C9CYP2C19MAPT
SCHEMBL25876669 0.88 BACE1 (0.44) PLA2G2AMAPK8RXFP1BACE1NR4A2
SCHEMBL9899016 0.88 NR4A2 (0.50) BACE1GABRA1GABRG2GABRB3GABRA3
SCHEMBL9934162 0.88 NR4A2 (0.46) PLA2G2ANR4A2MAPT
SCHEMBL1009498 0.87 TSHR (0.48) MAPK8GABRA1GABRG2GABRB3GABRA3
SCHEMBL31435276 0.86 KDM4E (0.46) KDM4ECYP1A2CYP2C9CYP2C19MAPT
SCHEMBL1332988 0.86 KDM4E (0.46) KDM4ECYP1A2CYP2C9CYP2C19MAPT
SCHEMBL6169984 0.86 RAB9A (0.40) PLA2G2AMAPK8KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12247035-B2 Articles comprising indolenaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2025-03-11 US disclosed
CN-113227099-B Articles comprising indolonaphthopyrans 光学转变有限公司 2025-03-11 CN disclosed
EP-3898635-B1 ARTICLES COMPRISING INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2024-12-04 EP disclosed
US-20220064175-A1 Articles Comprising Indolenaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2022-03-03 US disclosed
CN-113227099-A Articles comprising indole naphthopyrans 光学转变有限公司 2021-08-06 CN disclosed
US-8647538-B2 Photochromic compounds having at least two photochromic moieties TRANSITIONS OPTICAL, INC. (US) 2014-02-11 US disclosed
WO-2013078086-A1 PHOTOCHROMIC COMPOUNDS HAVING AT LEAST TWO PHOTOCHROMIC MOIETIES TRANSITIONS OPTICAL, INC. (US) 2013-05-30 WO disclosed
US-20120136148-A1 Photochromic Compounds Having At Least Two Photochromic Moieties TRANSITIONS OPTICAL, INC. (US) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220064175-A1 Articles Comprising Indolenaphthopyrans CDC25B, ACTB, CCNB1 PLA2G2A 519/4885MAPK8 3421/4885RXFP1 2466/4885
US-20120136148-A1 Photochromic Compounds Having At Least Two Photochromic Moieties CRY2, PCNA, MTCL3 PLA2G2A 2201/4885MAPK8 4168/4885RXFP1 4411/4885
US-12247035-B2 Articles comprising indolenaphthopyrans ACTB, CCNB1, HMBS PLA2G2A 666/4885MAPK8 3641/4885RXFP1 2130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.